About Us
RRH Pharma is a global pharmaceutical solutions provider focused on delivering high-quality Active Pharmaceutical Ingredients (APIs), intermediates, and finished formulations to international markets.
RRH Pharma is a global pharmaceutical solutions provider focused on delivering high-quality Active Pharmaceutical Ingredients (APIs), intermediates, and finished formulations to international markets.
High-Purity Solutions for Global Healthcare
RRH Pharma supports global partners in the development, sourcing, and supply of high-value innovator and orphan drugs designed to address rare diseases and critical therapeutic needs.
These specialized therapies represent the forefront of modern medicine, offering life-changing solutions for conditions with limited or no existing treatments. Through strong partnerships with research-driven organizations and regulatory experts, we ensure access to advanced, compliant, and globally aligned pharmaceutical solutions.
| Sr.No | Product | Dosage | Strength | Therapeutic Category |
|---|---|---|---|---|
| 1 | Valsartan | Tablets | 40, 80, 160, 320 mg | Antihypertensive |
| 2 | Furosemide | Tablets | 20, 40, 80 mg | Diuretic & Antihypertensive |
| 3 | Nitazoxanide | Tablets | 500 mg | Antiprotozoal |
| 4 | Trientine Dihydrochloride | Capsules | 250, 300 mg | Wilson's Disease |
| 5 | Sugammadex Sodium | Injection | Eq. 200 mg/2ml, 500 mg/5ml Base | NMJ Reversal |
| 6 | Clozapine | Tablets | 25, 50, 100, 200 mg | Antipsychotic |
| 7 | Vigabatrin | Tablets | 500 mg | Antiepileptic |
| 8 | Tolvaptan (Jynarc) | Tablets | 15, 30, 45, 60, 90 mg | ADPKD |
| 9 | Bilastine | Tablets | 20 mg | Antiallergic |
| 10 | Eltrombopag Olamine | Tablets | Eq. 12.5, 25, 50, 75 mg Acid | Thrombocytopenia |
| 11 | Nirmatrelvir + Ritonavir | Tablets | 150 + 100 mg | Covid Antiviral |
| 12 | Nitisinone | Capsules | 2, 5, 10, 20 mg | Hereditary Tyrosinemia |
Delivering comprehensive pharmaceutical solutions through innovation, compliance, and global expertise.
Access to innovator and orphan drug molecules through reliable global sourcing networks.
End-to-end support for regulatory submissions, documentation, and compliance processes.
Strategic collaboration with research partners for scale-up and commercialization.
Tailored formulation and product development solutions based on client requirements.
Adherence to region-specific regulations and orphan drug compliance standards.
Strong export capabilities ensuring reliable supply across international markets.
